Sanna Shaban
Surgical · Franklin, TNNPI 1528572823
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Amgen at 36.5% of the total. Reporting peaked in 2021 at $1,580 and has fallen 99.1% since, to $15 in 2025.
Across 119 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$735
- UCB, Inc.$282
- Novartis$242
- AbbVie$214
- Lilly USA, LLC$157
- Johnson & Johnson$70
- plus $314 from 8 others
What the payments were for
- Food & beverage$2,015100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 44 | $735 |
| UCB, Inc. | 16 | $282 |
| Novartis | 14 | $242 |
| AbbVie | 14 | $214 |
| Lilly USA, LLC | 10 | $157 |
| Johnson & Johnson | 4 | $70 |
| GSK | 3 | $64 |
| Sobi, Inc | 3 | $57 |
| AstraZeneca | 3 | $55 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Radius Health, Inc. | 3 | $43 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Vertex | 1 | $15 |
| Aurinia Pharma U.S., Inc. | 1 | $14 |
How this compares
$2,015 in reported general payments places this provider in the 80th percentile of 206 surgical providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $7,070 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 196 | $1,668 |
| Nabumetone | 72 | $997 |
| Methylprednisolone | 71 | $486 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 58 | $236 |
| Meloxicam | 65 | $193 |
| Tramadol Hcl | 55 | $135 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $63 |
| Ondansetron Hcl | 16 | $60 |
| Cephalexin | 31 | $57 |
| Tizanidine Hcl | 13 | $30 |
Paid to pharmacies, not to this prescriber.
Other surgical in Franklin
- Charlotte ShyFranklin$4K
- McKenzie LeteFranklin$4K
- Kristin GillelandFranklin$3K
- Douglas EasthamFranklin$2K
- Jennifer RuffFranklin$2K
- Hayley AndersonFranklin$2K
- Charlotte SauterFranklin$1K
- Stephen DevriesNashville$57K
- Elizabeth HaggertyNashville$9K
- Jennie ClarkKnoxville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.